{
  "column-order": [
    "Ampicillin",
    "Pip-Tazo",
    "Oxacillin",
    "Cefazolin",
    "Ceftriaxone",
    "Cefepime",
    "Meropenem",
    "Gentamicin",
    "Tobramicin",
    "Ciprofloxacin",
    "Levofloxacin",
    "TMP-SMX"
  ],
  "row-order": [
    "Enterobacter cloacae",
    "Escherichia coli",
    "Klebsiella pneumoniae",
    "Proteus mirabilis",
    "Pseudomonas aeruginosa"
  ],
  "footnotes": [
    "Organisms with less than 30 isolates are excluded due to small sample size",
    "CLSI breakpoints for pip/tazo and cefepime applied to Pseudomonas spp.",
    "Tetracycline predicts doxycycline activity",
    "Levofloxacin susceptibilty not published, however Ciprofloxacin traditionally closely predicts levofloxacin activity for Pseudomonas",
    "R= Intrinsic (i.e. not acquired) resistance. All wild-type isolates are expected to display resistance"
  ],
  "resistance-rates": [{ "label": "ESBL", "rate": "17.3", "year": 2021 }]
}
